Developer docs
API playgroundTry for free, no card

Search company profiles

Medkoo Biosciences

Full company profile

uuid000msio

Namestring
Medkoo Biosciences
Legal namestring
MedKoo Biosciences, Inc.
Websiteurl
medkoo.com
Company typeenum
Private
Founded yearint
2009
Descriptiontext

MedKoo Biosciences, Inc. is a US-based specialty supplier of small molecule research drugs and biochemical reagents founded in 2009 by Dr. Qingqi Chen and headquartered in the Research Triangle Park area of Durham, North Carolina. The company operates a catalogue of more than 7,000 research-grade compounds spanning approved drugs, discontinued drugs, drug candidates, inhibitors, agonists, fluorescent probes, and imaging agents across 25+ research areas, supplemented by a structured service portfolio that includes custom organic synthesis (with stated capacity of 300-400 complex compounds per year), process research and development, antibody-drug conjugation, bioconjugate and diagnostic bioconjugate synthesis, and hapten design. The company emphasizes a 100% quality guarantee backed by NMR, HPLC, and MS testing on every batch and has secured exclusive inbound licences on eight academic tool compounds from Vanderbilt, Tohoku, NYU/Pittsburgh, and University of Florida between 2024 and 2025.

The business model combines catalog sales (unit-priced per mg, gram, or bulk quantity) with project-priced custom synthesis engagements (minimum 1g order), plus CRO-style services in conjugation and process development. Products are sold exclusively for research use; no GMP, DMF, ISO, or DEA certifications are claimed. Distribution runs through direct e-commerce on medkoo.com (with same-day shipping from the Durham warehouse), offline purchase orders via email/fax/phone with Net 30 terms for qualified buyers, and an international distributor network. Marketing relies on the website, organic social media, downloadable technical catalogues, peer-reviewed journal citations (products cited in Nature, Cell, Nat Commun, Nat Biotechnol, and Nat Chem Biol), and trade shows.

Customer segments span academic research institutions, biotechnology companies, pharmaceutical companies, and biomedical research institutions. MedKoo has been awarded NIH biomedical research contracts in September 2021 (75N95021P00528) and September 2022 (75N95022P00731). The company remains privately held, founder-led, and operates with a disclosed headcount of 1-10 employees, with no external private equity or venture capital involvement identified in the available data. Revenue is not publicly disclosed.

Short descriptiontext

MedKoo Biosciences is a privately held US supplier of 7,000+ small molecule research compounds and custom synthesis services, serving academic, biotech, pharmaceutical, and biomedical research laboratories through direct e-commerce and CRO engagements.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersDurham, United States
HQ citystring
Durham
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biochemical reagents supplier, small molecule drugs, custom organic synthesis, kinase inhibitors, research chemicals catalog
Industry3 codes
PRIMARYHLAGAHAM
Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAAAD
Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity)
SECONDARYHLAGAFAC
DMPK / ADME & Bioanalysis
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)
NAICS code3 codes
  • Scientific Research and Development Services5417
  • Pharmaceutical Preparation Manufacturing325412
  • Pharmaceutical and Medicine Manufacturing3254
SIC code3 codes
  • Services-Commercial Physical & Biological Research8731
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
  • Pharmaceutical Preparations2834
Product category
Research-Grade Biochemical Reagents
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Product Sales
TypeOne Time License
Description

Sale of biochemical reagents and small molecule drugs for laboratory research use. Products range from milligrams to kilograms with unit-based pricing.

medkoo.com
2Custom Synthesis Services
TypeProfessional Services
Description

Custom organic synthesis services for complex, hard-to-source compounds. Minimum order 1g. Pricing and lead time vary by compound complexity.

medkoo.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
Pricing details2 tiers
1Catalog products - unit pricing by size
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Products priced per mg, gram, or bulk quantity. Example: Selumetinib sulfate 1g/USD 450, 2g/USD 750, 5g/USD 1450, 10g/USD 2450. DOTA-GPC3 1mg/USD 750, 5mg/USD 1650, 10mg/USD 2950. Tifeglipron 25mg/USD 950, 50mg/USD 1650, 100mg/USD 2650, 500g/USD 4650.

medkoo.com
2Custom synthesis - project-based pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Custom synthesis minimum order 1g. Lead time and cost vary by compound structure complexity. Contact sales@medkoo.com for quotes. Quote not offered for quantities below 1g.

medkoo.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

MedKoo Biosciences supplies a catalog of more than 7,000 research-grade small molecule drugs, kinase inhibitors, biochemical reagents, fluorescent probes, and imaging agents for laboratory research. The company also offers fee-based custom organic synthesis, process research and development, antibody-drug conjugation, bioconjugate synthesis, diagnostic bioconjugate development, and hapten design services, shipping worldwide from its Durham, NC warehouse.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 100% quality guarantee on all products with NMR, HPLC, MS analysis
+2 more records
Product overview1 text field

Medkoo Biosciences operates as a supplier of high-quality biochemical reagents specializing in small molecule drugs for laboratory research. The core offering consists of an extensive catalog of small molecule research compounds with related chemical information (CAS numbers, purity data, QC documentation). The portfolio includes custom synthesis services (capable of producing 300-400 complex compounds annually), process research and development, antibody-drug conjugation, bioconjugate synthesis, diagnostic bioconjugate development, and hapten design services. The company also provides supporting tools including a drug synthesis database, structure search functionality, and online ordering platform. All products are for research use only, not for human or veterinary use.

Product and service7 records
1Small Molecule Research Drugs Catalog
CategoryResearch-grade biochemical reagents
Description

Catalog of high-quality biochemical reagents and small molecule drugs for laboratory research use, covering approved drugs, discontinued compounds, drug candidates, kinase inhibitors, agonists, fluorescent probes, and imaging agents for academic, biotechnology, biomedical, and pharmaceutical researchers.

2Custom Synthesis
CategoryCustom synthesis services
Description

Custom organic synthesis services including synthesis of drug candidates, reference compounds, newly published compounds, synthetic route design, process development, and bulk quantity manufacturing, with a 1g minimum order and the capability to produce 300–400 complex compounds per year.

3Process Research & Development
CategoryContract research services
Description

CRO service for scalable process identification including process characterization and validation, reaction optimization, catalyst screening, crystallization studies, salt selection and polymorph screening, impurity profiling, and API synthesis for GLP toxicology through clinical studies.

4Antibody Drug Conjugation
CategoryCustom conjugation services
Description

Site-specific antibody-drug conjugation services using traditional and proprietary conjugation strategies, linking drugs or toxins to antibodies with characterization by SEC and UV/Vis spectrometry for targeted cancer therapy applications.

5Bioconjugate Synthesis
CategoryCustom conjugation services
Description

Custom bioconjugation and labeling services including infrared and visible dye labeling for antibodies, proteins, peptides, enzymes, small molecules, lectins, polymers, and nanoparticles, with derivatization chemistries including NHS Ester, Maleimide, Azide, Alkyne, DBCO, Hydrazide, and Amine.

6Diagnostic Bioconjugates
CategoryCustom conjugation services
Description

Portfolio of bioconjugates for diagnostic and medical imaging companies, including peptide-macrocyclic metal conjugates, antibody-luminex bead conjugates, oligonucleotide conjugates, enzyme-based bioconjugates, and microsphere/nanosphere conjugates.

7Hapten Design and Synthesis
CategoryCustom synthesis services
Description

Design and synthesis of haptens for immunoassay development, including linker attachment positioning, total synthesis, linker length design, and drug-to-carrier protein ratio control, with 20 years of experience in small molecule antibody development.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Tocris supplies small-molecule research tools, inhibitors, and tool compounds to academic and pharma researchers—directly overlapping with MedKoo's catalog of kinase inhibitors, agonists, and reference compounds. As a Bio-Techne brand, it shares the same research-use, lab-bench customer base.

TypeDirect peer
Description

Cayman is a leading supplier of biochemical reagents, antibodies, and small-molecule research compounds serving academic and pharma research. Its catalog breadth, custom synthesis capabilities, and immunoassay/hapten offerings are directly comparable to MedKoo's portfolio.

TypeDirect peer
Description

Selleck is a specialty supplier of small-molecule inhibitors, particularly in oncology, with a deep catalog of FDA-approved and clinical-stage compounds. Its positioning as a kinase-inhibitor-focused supplier maps closely to MedKoo's anticancer reagent focus.

TypeDirect peer
Description

MCE is a fast-growing global supplier of small-molecule inhibitors, reference compounds, and biochemical reagents with strong e-commerce and international logistics. It directly competes with MedKoo across kinase inhibitors, tool compounds, and natural product derivatives.

5Santa Cruz Biotechnology
TypeDirect peer
Description

Santa Cruz Biotechnology supplies antibodies, biochemical reagents, and small-molecule research compounds to academic and biotech researchers. Its catalog breadth and research-use-only positioning closely parallel MedKoo's go-to-market.

TypeDirect peer
Description

TCI is a global manufacturer of fine chemicals, organic intermediates, and research reagents with extensive catalog coverage. Its custom synthesis and bulk manufacturing services overlap directly with MedKoo's process R&D and custom synthesis offerings.

TypeBroad incumbent
Description

Sigma-Aldrich (Merck KGaA/MilliporeSigma) is the dominant global biochemical reagent supplier with massive catalog depth, GMP capabilities, and global distribution. It competes with MedKoo across virtually all reagent categories but at vastly greater scale and breadth.

TypeDirect peer
Description

BOC Sciences is a custom synthesis CRO and biochemical reagent supplier offering reference compounds, intermediates, and process R&D services. Its e-commerce catalog and project-based custom synthesis directly overlap with MedKoo's hybrid product/service model.

TypeDirect peer
Description

Enamine is a leading supplier of screening compounds, building blocks, and custom synthesis services for drug discovery. Its chemical catalog and on-demand custom synthesis capabilities are directly comparable to MedKoo's research compound offering.

TypeDirect peer
Description

Biosynth supplies biochemicals, carbohydrates, nucleosides, and life-science reagents with a focus on catalog and custom synthesis. Its reagent-and-services mix and research-use customer base align closely with MedKoo's positioning.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Medkoo Biosciences

Research-Grade Biochemical Reagentsmedkoo.com

MedKoo Biosciences is a privately held US supplier of 7,000+ small molecule research compounds and custom synthesis services, serving academic, biotech, pharmaceutical, and biomedical research laboratories through direct e-commerce and CRO engagements.

What Medkoo Biosciences does

MedKoo Biosciences, Inc. is a US-based specialty supplier of small molecule research drugs and biochemical reagents founded in 2009 by Dr. Qingqi Chen and headquartered in the Research Triangle Park area of Durham, North Carolina. The company operates a catalogue of more than 7,000 research-grade compounds spanning approved drugs, discontinued drugs, drug candidates, inhibitors, agonists, fluorescent probes, and imaging agents across 25+ research areas, supplemented by a structured service portfolio that includes custom organic synthesis (with stated capacity of 300-400 complex compounds per year), process research and development, antibody-drug conjugation, bioconjugate and diagnostic bioconjugate synthesis, and hapten design. The company emphasizes a 100% quality guarantee backed by NMR, HPLC, and MS testing on every batch and has secured exclusive inbound licences on eight academic tool compounds from Vanderbilt, Tohoku, NYU/Pittsburgh, and University of Florida between 2024 and 2025.

The business model combines catalog sales (unit-priced per mg, gram, or bulk quantity) with project-priced custom synthesis engagements (minimum 1g order), plus CRO-style services in conjugation and process development. Products are sold exclusively for research use; no GMP, DMF, ISO, or DEA certifications are claimed. Distribution runs through direct e-commerce on medkoo.com (with same-day shipping from the Durham warehouse), offline purchase orders via email/fax/phone with Net 30 terms for qualified buyers, and an international distributor network. Marketing relies on the website, organic social media, downloadable technical catalogues, peer-reviewed journal citations (products cited in Nature, Cell, Nat Commun, Nat Biotechnol, and Nat Chem Biol), and trade shows.

Customer segments span academic research institutions, biotechnology companies, pharmaceutical companies, and biomedical research institutions. MedKoo has been awarded NIH biomedical research contracts in September 2021 (75N95021P00528) and September 2022 (75N95022P00731). The company remains privately held, founder-led, and operates with a disclosed headcount of 1-10 employees, with no external private equity or venture capital involvement identified in the available data. Revenue is not publicly disclosed.

Medkoo Biosciences firmographics

Firmographics
Name
Medkoo Biosciences
Legal name
MedKoo Biosciences, Inc.
Website
https://medkoo.com
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
1–10 employees
Short description
MedKoo Biosciences is a privately held US supplier of 7,000+ small molecule research compounds and custom synthesis services, serving academic, biotech, pharmaceutical, and biomedical research laboratories through direct e-commerce and CRO engagements.
Ownership category
akta.pro rank

Medkoo Biosciences industry classification

Industry
Product category
Research-Grade Biochemical Reagents
NAICS
Scientific Research and Development Services (5417), Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)
SIC
Services-Commercial Physical & Biological Research (8731), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAGAHAM
Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAAAD
Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity)
SECONDARYHLAGAFAC
DMPK / ADME & Bioanalysis
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)

Keywords

  • Biochemical reagents supplier
  • Small molecule drugs
  • Custom organic synthesis
  • Kinase inhibitors
  • Research chemicals catalog

Where Medkoo Biosciences is headquartered

Location

Headquarters

HQ city
Durham
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Medkoo Biosciences business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Product Sales: Sale of biochemical reagents and small molecule drugs for laboratory research use. Products range from milligrams to kilograms with unit-based pricing.
  2. Custom Synthesis Services: Custom organic synthesis services for complex, hard-to-source compounds. Minimum order 1g. Pricing and lead time vary by compound complexity.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goCatalog products - unit pricing by size
OtherMulti-year contractCustom synthesis - project-based pricing

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Medkoo Biosciences product offering

Product offering

Core offering

MedKoo Biosciences supplies a catalog of more than 7,000 research-grade small molecule drugs, kinase inhibitors, biochemical reagents, fluorescent probes, and imaging agents for laboratory research. The company also offers fee-based custom organic synthesis, process research and development, antibody-drug conjugation, bioconjugate synthesis, diagnostic bioconjugate development, and hapten design services, shipping worldwide from its Durham, NC warehouse.

Product overview

Medkoo Biosciences operates as a supplier of high-quality biochemical reagents specializing in small molecule drugs for laboratory research. The core offering consists of an extensive catalog of small molecule research compounds with related chemical information (CAS numbers, purity data, QC documentation). The portfolio includes custom synthesis services (capable of producing 300-400 complex compounds annually), process research and development, antibody-drug conjugation, bioconjugate synthesis, diagnostic bioconjugate development, and hapten design services. The company also provides supporting tools including a drug synthesis database, structure search functionality, and online ordering platform. All products are for research use only, not for human or veterinary use.

Differentiator

Problem solved

Functional benefit

Products and services

  • Small Molecule Research Drugs Catalog Catalog of high-quality biochemical reagents and small molecule drugs for laboratory research use, covering approved drugs, discontinued compounds, drug candidates, kinase inhibitors, agonists, fluorescent probes, and imaging agents for academic, biotechnology, biomedical, and pharmaceutical researchers.
  • Custom Synthesis Custom organic synthesis services including synthesis of drug candidates, reference compounds, newly published compounds, synthetic route design, process development, and bulk quantity manufacturing, with a 1g minimum order and the capability to produce 300–400 complex compounds per year.
  • Process Research & Development CRO service for scalable process identification including process characterization and validation, reaction optimization, catalyst screening, crystallization studies, salt selection and polymorph screening, impurity profiling, and API synthesis for GLP toxicology through clinical studies.
  • Antibody Drug Conjugation Site-specific antibody-drug conjugation services using traditional and proprietary conjugation strategies, linking drugs or toxins to antibodies with characterization by SEC and UV/Vis spectrometry for targeted cancer therapy applications.
  • Bioconjugate Synthesis Custom bioconjugation and labeling services including infrared and visible dye labeling for antibodies, proteins, peptides, enzymes, small molecules, lectins, polymers, and nanoparticles, with derivatization chemistries including NHS Ester, Maleimide, Azide, Alkyne, DBCO, Hydrazide, and Amine.
  • Diagnostic Bioconjugates Portfolio of bioconjugates for diagnostic and medical imaging companies, including peptide-macrocyclic metal conjugates, antibody-luminex bead conjugates, oligonucleotide conjugates, enzyme-based bioconjugates, and microsphere/nanosphere conjugates.
  • Hapten Design and Synthesis Design and synthesis of haptens for immunoassay development, including linker attachment positioning, total synthesis, linker length design, and drug-to-carrier protein ratio control, with 20 years of experience in small molecule antibody development.

Quantifiable outcome

  • 100% quality guarantee on all products with NMR, HPLC, MS analysis
  • +2 more outcomes

Companies that use Medkoo Biosciences

Customer profile

Segments4 records

Ideal customer profiles3 records

Medkoo Biosciences technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Medkoo Biosciences partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves7 records

Expansion highlights4 records

Medkoo Biosciences competitors and assessment

Company assessment

Direct peers

  • Tocris Bioscience (Bio-Techne): Tocris supplies small-molecule research tools, inhibitors, and tool compounds to academic and pharma researchers—directly overlapping with MedKoo's catalog of kinase inhibitors, agonists, and reference compounds. As a Bio-Techne brand, it shares the same research-use, lab-bench customer base.
  • Cayman Chemical: Cayman is a leading supplier of biochemical reagents, antibodies, and small-molecule research compounds serving academic and pharma research. Its catalog breadth, custom synthesis capabilities, and immunoassay/hapten offerings are directly comparable to MedKoo's portfolio.
  • Selleck Chemicals: Selleck is a specialty supplier of small-molecule inhibitors, particularly in oncology, with a deep catalog of FDA-approved and clinical-stage compounds. Its positioning as a kinase-inhibitor-focused supplier maps closely to MedKoo's anticancer reagent focus.
  • MedChemExpress (MCE): MCE is a fast-growing global supplier of small-molecule inhibitors, reference compounds, and biochemical reagents with strong e-commerce and international logistics. It directly competes with MedKoo across kinase inhibitors, tool compounds, and natural product derivatives.
  • Santa Cruz Biotechnology: Santa Cruz Biotechnology supplies antibodies, biochemical reagents, and small-molecule research compounds to academic and biotech researchers. Its catalog breadth and research-use-only positioning closely parallel MedKoo's go-to-market.
  • TCI Chemicals: TCI is a global manufacturer of fine chemicals, organic intermediates, and research reagents with extensive catalog coverage. Its custom synthesis and bulk manufacturing services overlap directly with MedKoo's process R&D and custom synthesis offerings.
  • BOC Sciences: BOC Sciences is a custom synthesis CRO and biochemical reagent supplier offering reference compounds, intermediates, and process R&D services. Its e-commerce catalog and project-based custom synthesis directly overlap with MedKoo's hybrid product/service model.
  • Enamine: Enamine is a leading supplier of screening compounds, building blocks, and custom synthesis services for drug discovery. Its chemical catalog and on-demand custom synthesis capabilities are directly comparable to MedKoo's research compound offering.
  • Biosynth (formerly Carbosynth): Biosynth supplies biochemicals, carbohydrates, nucleosides, and life-science reagents with a focus on catalog and custom synthesis. Its reagent-and-services mix and research-use customer base align closely with MedKoo's positioning.

Broad incumbents

  • Sigma-Aldrich (Merck): Sigma-Aldrich (Merck KGaA/MilliporeSigma) is the dominant global biochemical reagent supplier with massive catalog depth, GMP capabilities, and global distribution. It competes with MedKoo across virtually all reagent categories but at vastly greater scale and breadth.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Medkoo Biosciences social profiles

Digital presence

Medkoo Biosciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Medkoo Biosciences leadership team

Management profile

Number of profiles

Profiles1 record

Medkoo Biosciences funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Medkoo Biosciences M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medkoo Biosciences

What does Medkoo Biosciences do?

MedKoo Biosciences supplies a catalog of more than 7,000 research-grade small molecule drugs, kinase inhibitors, biochemical reagents, fluorescent probes, and imaging agents for laboratory research. The company also offers fee-based custom organic synthesis, process research and development, antibody-drug conjugation, bioconjugate synthesis, diagnostic bioconjugate development, and hapten design services, shipping worldwide from its Durham, NC warehouse.

Is Medkoo Biosciences a public or private company?

Medkoo Biosciences is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Medkoo Biosciences founded?

Medkoo Biosciences was founded in 2009. It employs 1 to 10 people.

Where is Medkoo Biosciences based?

Medkoo Biosciences is headquartered in Durham, United States, in the North America region.

How does Medkoo Biosciences make money?

Two revenue lines are on record. Product Sales are the primary driver. The others are custom Synthesis Services.

Who are Medkoo Biosciences's main competitors?

Direct peers on record are Tocris Bioscience (Bio-Techne), Cayman Chemical, Selleck Chemicals, MedChemExpress (MCE), Santa Cruz Biotechnology, TCI Chemicals, BOC Sciences, Enamine and Biosynth (formerly Carbosynth). Sigma-Aldrich (Merck) is listed as a broad incumbent.

Does Medkoo Biosciences have an API?

No public API is recorded for Medkoo Biosciences.

What industry is Medkoo Biosciences in?

Medkoo Biosciences's product category is Research-Grade Biochemical Reagents. Its primary akta.pro industry code is HLAGAHAM, Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC), with a secondary code of HLAGAAAD, Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales